Loni Da Silva ’95 is one of Miami’s Top 25 Healthcare Technology Leaders, according to The Healthcare Technology Report. Da Silva is the senior vice president of regulatory affairs at Oyster Point Pharma, a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies to address ophthalmic disease.
